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Abstract 22 
Diabetes mellitus (DM) is a serious metabolic disorder where impaired postprandial 23 
blood glucose regulation often leads to severe health complications. The natural 24 
chemical, erythritol is a C4 polyol approved by FDA for use as a sweetener. Here we 25 
examined a potential role for erythritol in the control of postprandial blood glucose 26 
levels in DM. An anti-postprandial hyperglycemia effect upon erythritol 27 
administration (500 mg kg-1) was demonstrated in alloxan-induced DM model mice 28 
by monitoring changes in blood glucose after intragastric administration of drugs and 29 
starch. We also found that erythritol most likely exerts its anti-postprandial 30 
hyperglycemic activities by inhibiting α-glucosidase in a competitive manner. This 31 
was supported by enzyme activity assays and molecular modelling experiments. In the 32 
latter experiments it was possible to successful dock erythritol into the catalytic 33 
pocket of α-glucosidase, with the resultant interaction likely to be driven by 34 
electrostatic interactions involving Asp 215, Asp69 and Arg446 residues. This study 35 
suggests that erythritol may not only serve as a glucose substitute but may also be a 36 
useful agent in the treatment of diabetes mellitus to help manage postprandial blood 37 
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Diabetes mellitus (DM), is a disorder characterized by high blood glucose levels 48 
(>126 mg/dL) that affects 415 million people worldwide. DM is recognized as a 49 
serious public health concern with the total number of those affected estimated to 50 
increase to 642 million by 20401. DM is associated with serious health complications 51 
including kidney failure, cardiovascular disease, visual impairment, cognitive decline 52 
and premature death2,3-4. Therefore, new effective therapies for DM are urgently 53 
required. 54 
Type 2 DM is identified as a staged reduction of insulin secretion in response to 55 
food glucose intake; hence, its primary pathological phenomenon is impaired 56 
postprandial glucose regulation5. However, clinicians still depend on fasting blood 57 
glucose and glycated hemoglobin to guide treatment6. It is reported that a linear 58 
relationship between the risk of death from cardiovascular disease and the oral 59 
glucose tolerance is observed7-8. Meanwhile, another study confirms postprandial 60 
hyperglycemia to be a major risk factor for cardiovascular disease in individuals with 61 
type 2 DM9-10. It is reported that postprandial hyperglycemia may promote 62 
cardiovascular disease by increasing oxidative stress11. Furthermore, it is suggested 63 
that postprandial hyperglycemia is a common phenomenon for individuals without 64 
DM12. Adequate control of postprandial glucose levels is thus very important and 65 
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should be given more attention13. 66 
In type 2 DM, α-glucosidase inhibitors are commonly used to control 67 
postprandial hyperglycemia14. The enzyme α-Glucosidase is a carbohydrase located 68 
on the surface intestinal epithelial cells, where it catalyses the hydrolysis of 69 
oligosaccharides into monosaccharides (such as glucose) to facilitate absorption. By 70 
significantly delaying intestinal glucose absorption, α-glucosidase inhibitors can 71 
reduce postprandial hyperglycemia to lower the risk of late diabetic complications14. 72 
Because of its tolerability and cardiovascular benefits, the International Diabetes 73 
Federation (IDF) have recommended α-glucosidase inhibitors as a first line therapy 74 
for DM15.  75 
Many sugar derivatives such as sugar alcohols, due to their low-energy character, 76 
have been developed into food additives as substitutes for glucose16. The sugar 77 
alcohol, erythritol exists naturally in algae, wine, sake, beer, pears, grapes, 78 
watermelons, and mushrooms and is a C4 polyol, which was approved in 1997 by the 79 
FDA to be listed in GRAS (Generally Recognized As Safe List). More than 90% of 80 
ingested erythritol is not metabolized by the human body and is excreted unchanged 81 
in the urine. Consequently, erythritol has a potential use as a sweetener that may be 82 
added to the diets of DM patients17.  83 
In a previous study, the effects of erythritol on blood glucose in streptozotocin 84 
(STZ)-induced DM rats was assessed. It was found that erythritol had a long-term 85 
blood glucose controlling capacity, that led to reduced kidney damage caused by 86 
DM18. Here we demonstrate that that erythritol is effective for controlling 87 
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postprandial hyperglycemia in alloxan-induced DM model mice and show that it 88 
likely mediates this effect by acting as a competitive inhibitor of α-glucosidase. 89 
 90 
Materials and methods 91 
Chemicals and reagents 92 
For the outlined studies, α-Glucosidase from Saccharomyces cerevisiae (EC 93 
3.2.1.20), erythritol, p-nitrophenyl-α-D-glucopyranoside (pNPG) and acarbose were 94 
obtained from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). All other 95 
chemicals used were of analytical grade. 96 
 97 
Animals 98 
Thirty SPF grade male Swiss albino male mice (balb/c strain), eight weeks old, 99 
were obtained from the SLAC Company Limited (Shanghai, China). Diabetes was 100 
induced by a single intravenous injection of aqueous alloxan monohydrate (200 101 
mg/kg). After 48 h, animals with the serum glucose level within the range (17-24 102 
mmol/L) were selected for the further study. All the animals were housed 5 per cage at 103 
25  with a 12 h light/12 h dark cycle. All experiments were approved by the Animal ℃104 
Ethics Committee of Chinese Academy of Sciences and were performed according to 105 
Guidelines for the Care and Use of Laboratory Animals. The animal ethical approval 106 
number is NWIPB-2016-33. 107 
The thirty mice were randomly allocated into six groups: sham operation plus 108 
water group (Sham Cn), sham plus acarbose solution (acarbose 4 mg/Kg/d), sham 109 
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plus erythritol solution (erythritol 500 mg/Kg/d), DM plus water (DM Cn), DM plus 110 
acarbose solution group (acarbose 4 mg/Kg/d) and DM plus erythritol solution 111 
(erythritol 500 mg/Kg/d). Erythritol was dissolved in water (vehicle) and was 112 
administered by intragastric administration with 0.5g starch after fasting for 12 hours. 113 
After intragastric administration, the blood glucose levels were measured at 0, 30, 60, 114 
100, 140 and 180 min. 115 
 116 
Assessment of α-Glucosidase activity 117 
The α-glucosidase activity assay was performed according to a slightly modified 118 
method of that previously reported19. The α-glucosidases (0.35 U/mL) and substrate 119 
(1.5 mM p-nitrophenyl-α-D-glucopyranoside) were dissolved in 0.1 M sodium 120 
phosphate buffer, pH 7.0. For this 50 µL of acarbose or erythritol was pre-incubated 121 
with 100 µL of α-glucosidase at 37  for 10 min. ℃ The substrate solution (100 µL) was 122 
then added to the reaction mixture and incubated at 37  for 20 min℃ . The reaction was 123 
then terminated by adding 1 ml of 1 M Na2CO3. The absorbance at 405 nm was 124 
determined using a microplate Reader (EnVision; PerkinElmer, USA). All samples 125 
were analyzed in triplicate and the percentage of activity was calculated as: 126 





Kinetic studies were also performed based on the α-glucosidase assay described 128 
above. The concentration of α-glucosidase was kept constant at 0.1 unit/mL and the 129 
pNPG concentrations varied from 0.11 to 0.51 mM in the absence and presence of 130 
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erythritol (5, 10 and 15 mg/mL). The type of inhibition was determined using Vmax 131 
and Km values obtained using a Lineweaver-Burke plot obtained by plotting velocities 132 
of reaction (vertical axis) and substrate concentrations (horizontal axis) reciprocally. 133 
 134 
Molecular modeling 135 
 Molecular docking studies were performed using Discovery studio v2.5 software 136 
(Accelrys Inc, San Diego, USA). The 3D structure of the α-glucosidase, isomaltase 137 
from Saccharomyces cerevisiae (PDB: 3AJ7) was obtained from Protein Data Bank 138 
(www.rcsb.org). This structure was chosen based on its very high resolution (1.3 Å). 139 
Crystallographic disorders and unfilled valence atoms were corrected by alternate 140 
conformations and valence monitor tools. The molecular docking of erythritol was 141 
performed using the Libdock method. To begin the docking, hydrogen bonds were 142 
added firstly, and then the energy was minimized by CHARMM force field. After the 143 
above steps of preparations, the active site of the enzyme was identified as the binding 144 
site to start the docking protocol.  145 
The AMBER 11.0 software was employed to run all the molecular dynamics 146 
studies. Erythritol was minimized by the Discovery studio v2.5 software. General 147 
Amber Force Field (GAFF) parameters were firstly assigned to the ligands, while 148 
partial charges were calculated using the AM1-BCC method of AMBER 11.0. The 149 
erythritol-enzyme complex was charge neutralized by adding 10 sodium counter ions, 150 
and then were surrounded by a periodic box of TIP3P water molecules extending up 151 
to 10 Ǻ from the solute. First, energy minimizations using a steepest descent method, 152 
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followed by the conjugate gradient method, were performed for each system. Then, 153 
each system was gradually heated from 0 K to 300 K within 30 ps. This was followed 154 
by a further 500 ps of equilibration at 300 K carried out to obtain a stable density. 155 
Afterward, an unconstrained production phase was initiated and continued for 40 ns in 156 
an NPT ensemble at 1 atm and 300 K. During the simulations, the long-range 157 
electrostatic interactions were evaluated by the Particle Mesh Ewald (PME) algorithm. 158 
The cutoff distance for the long-range van der Waals interaction was set to 8 Ǻ. The 159 
SHAKE method was applied to con-strain the bond lengths of hydrogen atoms 160 
attached to heteroatoms. The time step used for the MD simulations was set to 2.0 fs 161 
and the trajectory files were collected every 1 ps for the subsequent analysis.  162 
The interaction between inhibitor and each residue was computed using the 163 
MM/GBSA decomposition process by the mm_pbsa program in AMBER 11.0. The 164 
binding interaction of each inhibitor–residue pair includes three energy terms: van der 165 
Waals contribution (vdw), electrostatic contribution (ele) and polar solvation 166 
contribution (Polar E) and non-polar solvation contribution (non-Polar E). All energy 167 
components were calculated using the 300 snapshots extracted from the MD 168 
trajectory from 1.0 to 4.0 ns. 169 
 170 
Results and discussion 171 
Reduction of postprandial blood glucose by erythritol 172 
The postprandial hypoglycemic effect of erythritol in an alloxan-induced DM 173 
mouse model was analyzed. Blood glucose was measured before and 30, 60, 100 and 174 
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140 min after intragastric administration of starch. The blood glucose increased and 175 
peaked at 30 minutes in all the groups. Compared with the sham operation plus water 176 
group (Sham Cn), the sham plus acarbose solution (acarbose 4 mg/Kg/d) and sham 177 
plus erythritol solution (erythritol 500 mg/Kg/d) groups both displayed a decrease in 178 
average blood glucose but the differences between the three groups were not 179 
considered to be significant (Figure 1A). Meanwhile, the area under the 180 
concentration-time curve (AUC) of the above three groups did not differ significantly 181 
(Figure 1B). The results indicated that erythritol and acarbose did not induce any 182 
significant postprandial blood glucose changes in healthy animals. However, in the 183 
DM-model animals, the postprandial hypoglycemic effect of erythritol and acarbose 184 
became significant (Figure 1C). A significant decline in AUC was observed for both 185 
erythritol and acarbose-treated groups, demonstrating both drugs to exert an in vivo 186 
postprandial hypoglycemic effect (Figure 1D). This finding was contrary to a previous 187 
report that found erythritol treatment to have no effect on blood glucose20. However, 188 
in that study fasting blood glucose levels and not postprandial blood glucose were 189 
measured. In a very recent report a postprandial hypoglycemic effect of erythritol was 190 
shown in vivo 21. However, this study focused specifically on the effects of erythritol 191 
on insulin resistance. 192 
 193 
Inhibition of α-glucosidase activity by erythritol 194 
The ability of erythritol to inhibit α-glucosidase was assessed. As shown in Figure 195 
2, erythritol exhibited a strong inhibitory effect displaying an IC50 value of 6.43 196 
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mg/mL (52.7 mM). This suggests that the mechanism by which erythritol exerts its 197 
postprandial hypoglycemic effect is potentially through direct inhibition of 198 
α-glucosidase. In healthy animals, under the hypoglycemic effect of insulin, it is 199 
likely that blood glucose concentrations are controlled so well that erythritol is unable 200 
to influence postprandial blood glucose (Figure 1A and 1B). However in the 201 
DM-model mice, in the absence of sufficient glycemic control by insulin, a reduction 202 
in the production of intestinal glucose by erythritol-mediated α-glucosidase inhibition 203 
could explain the significant difference observed. 204 
To determine the mechanism of inhibition kinetic studies were performed. For 205 
these, erythritol was added at three different concentrations (i.e. 5, 10 and 15 mg/mL) 206 
and the reacations performed a at five different pNPG (substrate) concentrations (i.e. 207 
0.11–0.51 mM). Product formation was first plotted against time to obtain initial 208 
velocities, which were calculated by taking the linear part of the increasing 209 
absorbance. The reciprocal velocities were subsequently plotted against the reciprocal 210 
of substrate concentration to construct Lineweaver-Burk plots. The Lineweaver–Burk 211 
plots for α-glucosidase inhibition by erythritol generated linear data with different 212 
granients, which intersected at the same point on Y-axis (indicative of an increased Km 213 
and unchanged Vmax), indicating competitive inhibition. The Ki value was calculated 214 
to be 38.98 mM at 5 mg/ml (Figure 3). 215 
 216 
Computational modeling of the α-glucosidase-erythritol complex 217 
A Ramachandran Plot, often used as a first check to verify predicted torsion 218 
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angles in proteins, showed low energy conformations for φ (phi) and ψ (psi), which 219 
were used to represent the torsion angles on either side of alpha carbons in peptides. 220 
The Ramachandran Plot provided the local backbone conformation of each residue by 221 
graphical expression form. The φ and ψ torsion angles of a residue were represented 222 
as the points on the Ramachandran Plot, which also included a representation of the 223 
favorable and unfavorable regions for residues to aid determination of whether 224 
individual residues were built correctly. As shown in Figure 4, most of the residues 225 
resided in either the core or allowed region with the exception of 9 residues (marked 226 
as red triangles), which overall indicated that the quality of the docking model was 227 
very good. 228 
Next, we carried out a Libdock protocol to study the interactions between the 229 
α-glucosidase enzyme and its inhibitor erythritol. During catalysis the Glu277 residue 230 
of the enzyme forms a hydrogen bond with O1 of the glucose saccharide, with a bond 231 
distance of 2.8 Å. The lengths of hydrogen bonds between Asp352 OD1 and O3 of the 232 
glucose residue and between OD2 and O2 are 2.7 and 2.5 Å, respectively. Asp69 OD2 233 
and Arg442 NH1 form hydrogen bonds with O4 of the glucose residue. Glu277, 234 
Asp352, Asp69 and Arg442 together form the active site of α-glucosidase. For 235 
erythritol (shown in Figure 5), a hydrogen-bond network was found at the two ends of 236 
the molecule. The hydroxyl group on the C1 carbon atom connected to Asp69 and 237 
Arg446 by hydrogen-bonds through the H113 water molecule. Another hydroxyl 238 
group on the C4 carbon atom made similar connections with Asp215, Arg213, Asp352 239 
through H132 water molecules. It was clearly observed in our model that the active 240 
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site of the enzyme was occupied by erythritol. We speculated that these H-bonds 241 
provide the main electrostatic means to aid erythritol binding at the active pocket and 242 
facilitate its demonstrated inhibitory activity. 243 
In order to gain more information as to the chemical properties of the 244 
erythritol-enzyme interactions, the binding free energy was decomposed into 245 
inhibitor-residue pairs. The resultant quantitative data (shown in Table 1) was very 246 
useful for understanding how erythritol could bind in the active pocket of 247 
α-glucosidase. It was demonstrated that the major binding energy was electrical free 248 
energy and the majority dissociation energy was polar solvation free energy. The van 249 
der Waals free energy, electrical free energy and non-polar solvation free energy were 250 
sufficient to overcome the polar solvation free energy to promote erythritol binding.  251 
To deepen our understanding on forces stabilizing the binding of erythritol to the 252 
enzyme, we decomposited the free energy of the residues in the active pocket 253 
proposed to interact with erythritol (Figure 6). It was demonstrated that Asp 215, 254 
Asp69 and Arg446 residues were likely to contribute the largest total binding free 255 
energy. By decomposition, we found that these three residues provided a high 256 
proportion of electrical free energy to promote erythritol binding in the active pocket, 257 
which we propose is provided by hydrogen-bonds. Moreover, these three residues 258 
undertake the largest polar solvent decomposition free energy. For Asp 352, Val 109 259 
and Arg213 residues, the most important binding energy was solar solvent free energy, 260 
while the main decomposition free energy was electrical free energy. In addition, we 261 
found that all the four kinds of energy could promote inhibitor-binding by His351 and 262 
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Val216 residues, in which van der Waals and polar solvent free energy provided the 263 
most energy. 264 
In summary, we have shown using an alloxan-induced DM mouse model that 265 
erythritol treatment significantly reduces postprandial blood glucose at the dose of 266 
500 mg/Kg compared with acarbose (4 mg/Kg), but has no significant effects on 267 
healthy animals. Biochemical analysis indicated that erythritol exerts its 268 
hypoglycemic effect by inhibiting α-glucosidase in the competitive manner. Molecular 269 
docking of erythritol to the α-glucosidase, isomaltase from S. cerevisiae revealed that 270 
the C1 hydroxyl and C4 hydroxyl groups of erythritol may form hydrogen-bonds with 271 
Asp69, Arg446, Asp215, Arg213 and Asp352 residues though H113 and H132 water 272 
molecules to competitively occupy the active pocket. An energy decomposition study 273 
indicated that electrical free energy provided the majority of the binding free energy 274 
and the polar solvent free energy provided the majority dissociation energy. The Asp 275 
215, Asp69 and Arg446 residues contributed the strongest total binding free energy. It 276 
is hoped that these findings will stimulate further work into the role of erythritol in the 277 
management of DM and its potential use as a therapeutic food additive. 278 
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 289 
Figure captions 290 
Figure 1 (A) After intragastric administration of erythritol (500 mg/Kg) and acarbose 291 
(4 mg/Kg) to healthy mice, the blood glucose was monitored at different time points. 292 
(B and D) the area under concentration-time curve (AUC) were calculated to evaluate 293 
the postprandial blood glucose changes. (C) After intragastric administration of 294 
erythritol (500 mg/Kg) and acarbose (4 mg/Kg) to diabetes mellitus mice, the blood 295 
glucose was monitored at different time points.  296 
Figure 2. Inhibition of α-glucosidase by acarbose (A) and erythritol (B). Data was 297 
fitted using a logistic function to calculate the IC50 values. The detailed inhibition data 298 
is presented. 299 
Figure 3. Lineweaver-Burk plot of erythritol-mediated α-glucosidase inhibition. Data 300 
is plotted as a double reciprocal of initial reactions velocities versus concentration of 301 
the substrate, pNPG. 302 
Figure 4. Ramachandran contours were used to test the quality of the presented 303 
molecular model. Green dots indicate the position of residues in the core region, while 304 
red triangles highlight the outlying residues. 305 
Figure 5. Molecular model of erythritol-binding at the catalytic active pocket of 306 
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α-glucosidase. The interacting protein residues, Asp 215, Asp69, Arg446, Asp 352, 307 
Val 109, Arg213, His351 and Val216 are highlighted. 308 
Figure 6. Decomposition of the calculated free energies of the Asp 215, Asp69, 309 
Arg446, Asp 352, Val 109, Arg213, His351 and Val216 residues, which are proposed 310 
to contribute to the binding of erythritol to α-glucosidase. 311 
 312 
 313 
Table 1 Total binding free energy decomposition (kJ/mol) 314 
Energy Component Average Std. Dev. 
VDWAALS -9.8652 3.3202 
EEL -69.2587 6.6086 
EGB 58.9938 4.1258 
ESURF -3.2684 0.1329 
DELTA G gas -79.1239 5.4402 
DELTA G solv 55.7253 4.1494 
DELTA TOTAL -23.3986 4.9532 
VDWAALS is total van der waals free energy. EEL is total electrical free energy. 315 
EGB is total polar solvation energy. ESURF is total non-polar solvation energy. 316 
DELTA G gas=VDWAALS+EEL. DELTA G solv= EGB+ ESURF. DELTA TOTAL= 317 
VDWAALS+ EEL+ EGB+ ESURF. 318 
 319 
 320 
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Figure 1 (A) After intragastric administration of erythritol (500 mg/Kg) and acarbose (4 mg/Kg) to healthy 
mice, the blood glucose was monitored at different time points. (C) After intragastric administration of 
erythritol (500 mg/Kg) and acarbose (4 mg/Kg) to diabetes mellitus mice, the blood glucose was monitored 
at different time points. (B and D) the area under concentration-time curve (AUC) were calculated to 
evaluate the postprandial blood glucose changes.  
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Figure 2 the inhibition data of acarbose (A) and erythritol (B) with different concentrations was fitted with 
logistic function to calculate the IC50 value. The detailed inhibition data was at the head of each figures.  
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Figure 3 Lineweaver-Burk plot of erythritol against α-glucosidase at different concentrations of pNPG.  
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Figure 4 Ramachandran contours is used to test the quality of newly developed model. Green dots donate 
the position of residues in core region. While, red spots sign highlights the outliers.  
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Figure 5 the interaction mode of erythritol in the catalytic active pocket of α-glucosidase with Asp 215, 
Asp69, Arg446, Asp 352, Val 109, Arg213, His351 and Val216.  
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Figure 6 Decomposition of the free energy of Asp 215, Asp69, Arg446, Asp 352, Val 109, Arg213, His351 
and Val216.  
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